AstraZeneca PLC 13D and 13G filings for Aridis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-10 10:25 am Unchanged | 2022-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS | AstraZeneca PLC | 884,956 3.400% | 0 (Unchanged) | Filing |
| 2021-07-27 1:20 pm Purchase | 2021-07-20 | 13G | Aridis Pharmaceuticals, Inc. ARDS | AstraZeneca PLC | 884,956 7.300% | 884,956 (New Position) | Filing |